1 Market Overview of Antisense Therapy 1.1 Antisense Therapy Market Overview 1.1.1 Antisense Therapy Product Scope 1.1.2 Antisense Therapy Market Status and Outlook 1.2 Global Antisense Therapy Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Antisense Therapy Market Size by Region (2016-2027) 1.4 Global Antisense Therapy Historic Market Size by Region (2016-2021) 1.5 Global Antisense Therapy Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Antisense Therapy Market Size (2016-2027) 1.6.1 North America Antisense Therapy Market Size (2016-2027) 1.6.2 Europe Antisense Therapy Market Size (2016-2027) 1.6.3 Asia-Pacific Antisense Therapy Market Size (2016-2027) 1.6.4 Latin America Antisense Therapy Market Size (2016-2027) 1.6.5 Middle East & Africa Antisense Therapy Market Size (2016-2027) 2 Antisense Therapy Market Overview by Type 2.1 Global Antisense Therapy Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Antisense Therapy Historic Market Size by Type (2016-2021) 2.3 Global Antisense Therapy Forecasted Market Size by Type (2022-2027) 2.4 RNA Antisense Therapy 2.5 DNA Antisense Therapy 3 Antisense Therapy Market Overview by Application 3.1 Global Antisense Therapy Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Antisense Therapy Historic Market Size by Application (2016-2021) 3.3 Global Antisense Therapy Forecasted Market Size by Application (2022-2027) 3.4 Cancer 3.5 Cardiovascular 3.6 HBV 3.7 Other 4 Antisense Therapy Competition Analysis by Players 4.1 Global Antisense Therapy Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antisense Therapy as of 2020) 4.3 Date of Key Players Enter into Antisense Therapy Market 4.4 Global Top Players Antisense Therapy Headquarters and Area Served 4.5 Key Players Antisense Therapy Product Solution and Service 4.6 Competitive Status 4.6.1 Antisense Therapy Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Alnylam Pharmaceuticals 5.1.1 Alnylam Pharmaceuticals Profile 5.1.2 Alnylam Pharmaceuticals Main Business 5.1.3 Alnylam Pharmaceuticals Antisense Therapy Products, Services and Solutions 5.1.4 Alnylam Pharmaceuticals Antisense Therapy Revenue (US$ Million) & (2016-2021) 5.1.5 Alnylam Pharmaceuticals Recent Developments 5.2 Ionis Pharmaceuticals, Inc. 5.2.1 Ionis Pharmaceuticals, Inc. Profile 5.2.2 Ionis Pharmaceuticals, Inc. Main Business 5.2.3 Ionis Pharmaceuticals, Inc. Antisense Therapy Products, Services and Solutions 5.2.4 Ionis Pharmaceuticals, Inc. Antisense Therapy Revenue (US$ Million) & (2016-2021) 5.2.5 Ionis Pharmaceuticals, Inc. Recent Developments 5.3 Arbutus Biopharma (Tekmira) 5.5.1 Arbutus Biopharma (Tekmira) Profile 5.3.2 Arbutus Biopharma (Tekmira) Main Business 5.3.3 Arbutus Biopharma (Tekmira) Antisense Therapy Products, Services and Solutions 5.3.4 Arbutus Biopharma (Tekmira) Antisense Therapy Revenue (US$ Million) & (2016-2021) 5.3.5 Isarna Therapeutics Recent Developments 5.4 Isarna Therapeutics 5.4.1 Isarna Therapeutics Profile 5.4.2 Isarna Therapeutics Main Business 5.4.3 Isarna Therapeutics Antisense Therapy Products, Services and Solutions 5.4.4 Isarna Therapeutics Antisense Therapy Revenue (US$ Million) & (2016-2021) 5.4.5 Isarna Therapeutics Recent Developments 5.5 Arrowhead 5.5.1 Arrowhead Profile 5.5.2 Arrowhead Main Business 5.5.3 Arrowhead Antisense Therapy Products, Services and Solutions 5.5.4 Arrowhead Antisense Therapy Revenue (US$ Million) & (2016-2021) 5.5.5 Arrowhead Recent Developments 5.6 Dicerna Pharmaceuticals 5.6.1 Dicerna Pharmaceuticals Profile 5.6.2 Dicerna Pharmaceuticals Main Business 5.6.3 Dicerna Pharmaceuticals Antisense Therapy Products, Services and Solutions 5.6.4 Dicerna Pharmaceuticals Antisense Therapy Revenue (US$ Million) & (2016-2021) 5.6.5 Dicerna Pharmaceuticals Recent Developments 5.7 Quark Pharmaceuticals 5.7.1 Quark Pharmaceuticals Profile 5.7.2 Quark Pharmaceuticals Main Business 5.7.3 Quark Pharmaceuticals Antisense Therapy Products, Services and Solutions 5.7.4 Quark Pharmaceuticals Antisense Therapy Revenue (US$ Million) & (2016-2021) 5.7.5 Quark Pharmaceuticals Recent Developments 5.8 Benitec Biopharma 5.8.1 Benitec Biopharma Profile 5.8.2 Benitec Biopharma Main Business 5.8.3 Benitec Biopharma Antisense Therapy Products, Services and Solutions 5.8.4 Benitec Biopharma Antisense Therapy Revenue (US$ Million) & (2016-2021) 5.8.5 Benitec Biopharma Recent Developments 5.9 Sylentis 5.9.1 Sylentis Profile 5.9.2 Sylentis Main Business 5.9.3 Sylentis Antisense Therapy Products, Services and Solutions 5.9.4 Sylentis Antisense Therapy Revenue (US$ Million) & (2016-2021) 5.9.5 Sylentis Recent Developments 5.10 Gradalis 5.10.1 Gradalis Profile 5.10.2 Gradalis Main Business 5.10.3 Gradalis Antisense Therapy Products, Services and Solutions 5.10.4 Gradalis Antisense Therapy Revenue (US$ Million) & (2016-2021) 5.10.5 Gradalis Recent Developments 5.11 Sarepta Therapeutics 5.11.1 Sarepta Therapeutics Profile 5.11.2 Sarepta Therapeutics Main Business 5.11.3 Sarepta Therapeutics Antisense Therapy Products, Services and Solutions 5.11.4 Sarepta Therapeutics Antisense Therapy Revenue (US$ Million) & (2016-2021) 5.11.5 Sarepta Therapeutics Recent Developments 5.12 Biogen 5.12.1 Biogen Profile 5.12.2 Biogen Main Business 5.12.3 Biogen Antisense Therapy Products, Services and Solutions 5.12.4 Biogen Antisense Therapy Revenue (US$ Million) & (2016-2021) 5.12.5 Biogen Recent Developments 6 North America 6.1 North America Antisense Therapy Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Antisense Therapy Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Antisense Therapy Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Antisense Therapy Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Antisense Therapy Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Antisense Therapy Market Dynamics 11.1 Antisense Therapy Industry Trends 11.2 Antisense Therapy Market Drivers 11.3 Antisense Therapy Market Challenges 11.4 Antisense Therapy Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Antisense Therapy Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Antisense Therapy Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Antisense Therapy Market Size Share by Region (2016-2021) Table 4. Global Antisense Therapy Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Antisense Therapy Forecasted Market Size Share by Region (2022-2027) Table 6. Global Antisense Therapy Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Antisense Therapy Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Antisense Therapy Revenue Market Share by Type (2016-2021) Table 9. Global Antisense Therapy Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Antisense Therapy Revenue Market Share by Type (2022-2027) Table 11. Global Antisense Therapy Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Antisense Therapy Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Antisense Therapy Revenue Market Share by Application (2016-2021) Table 14. Global Antisense Therapy Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Antisense Therapy Revenue Market Share by Application (2022-2027) Table 16. Global Antisense Therapy Revenue (US$ Million) by Players (2016-2021) Table 17. Global Antisense Therapy Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antisense Therapy as of 2020) Table 19. Date of Key Manufacturers Enter into Antisense Therapy Market Table 20. Global Antisense Therapy Top Players Headquarters and Area Served Table 21. Antisense Therapy Product Solution and Service Table 22. Global Antisense Therapy Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Alnylam Pharmaceuticals Basic Information List Table 25. Alnylam Pharmaceuticals Description and Business Overview Table 26. Alnylam Pharmaceuticals Antisense Therapy Products, Services and Solutions Table 27. Revenue (US$ Million) in Antisense Therapy Business of Alnylam Pharmaceuticals (2016-2021) Table 28. Alnylam Pharmaceuticals Recent Developments Table 29. Ionis Pharmaceuticals, Inc. Basic Information List Table 30. Ionis Pharmaceuticals, Inc. Description and Business Overview Table 31. Ionis Pharmaceuticals, Inc. Antisense Therapy Products, Services and Solutions Table 32. Revenue (US$ Million) in Antisense Therapy Business of Ionis Pharmaceuticals, Inc. (2016-2021) Table 33. Ionis Pharmaceuticals, Inc. Recent Developments Table 34. Arbutus Biopharma (Tekmira) Basic Information List Table 35. Arbutus Biopharma (Tekmira) Description and Business Overview Table 36. Arbutus Biopharma (Tekmira) Antisense Therapy Products, Services and Solutions Table 37. Revenue (US$ Million) in Antisense Therapy Business of Arbutus Biopharma (Tekmira) (2016-2021) Table 38. Arbutus Biopharma (Tekmira) Recent Developments Table 39. Isarna Therapeutics Basic Information List Table 40. Isarna Therapeutics Description and Business Overview Table 41. Isarna Therapeutics Antisense Therapy Products, Services and Solutions Table 42. Revenue (US$ Million) in Antisense Therapy Business of Isarna Therapeutics (2016-2021) Table 43. Isarna Therapeutics Recent Developments Table 44. Arrowhead Basic Information List Table 45. Arrowhead Description and Business Overview Table 46. Arrowhead Antisense Therapy Products, Services and Solutions Table 47. Revenue (US$ Million) in Antisense Therapy Business of Arrowhead (2016-2021) Table 48. Arrowhead Recent Developments Table 49. Dicerna Pharmaceuticals Basic Information List Table 50. Dicerna Pharmaceuticals Description and Business Overview Table 51. Dicerna Pharmaceuticals Antisense Therapy Products, Services and Solutions Table 52. Revenue (US$ Million) in Antisense Therapy Business of Dicerna Pharmaceuticals (2016-2021) Table 53. Dicerna Pharmaceuticals Recent Developments Table 54. Quark Pharmaceuticals Basic Information List Table 55. Quark Pharmaceuticals Description and Business Overview Table 56. Quark Pharmaceuticals Antisense Therapy Products, Services and Solutions Table 57. Revenue (US$ Million) in Antisense Therapy Business of Quark Pharmaceuticals (2016-2021) Table 58. Quark Pharmaceuticals Recent Developments Table 59. Benitec Biopharma Basic Information List Table 60. Benitec Biopharma Description and Business Overview Table 61. Benitec Biopharma Antisense Therapy Products, Services and Solutions Table 62. Revenue (US$ Million) in Antisense Therapy Business of Benitec Biopharma (2016-2021) Table 63. Benitec Biopharma Recent Developments Table 64. Sylentis Basic Information List Table 65. Sylentis Description and Business Overview Table 66. Sylentis Antisense Therapy Products, Services and Solutions Table 67. Revenue (US$ Million) in Antisense Therapy Business of Sylentis (2016-2021) Table 68. Sylentis Recent Developments Table 69. Gradalis Basic Information List Table 70. Gradalis Description and Business Overview Table 71. Gradalis Antisense Therapy Products, Services and Solutions Table 72. Revenue (US$ Million) in Antisense Therapy Business of Gradalis (2016-2021) Table 73. Gradalis Recent Developments Table 74. Sarepta Therapeutics Basic Information List Table 75. Sarepta Therapeutics Description and Business Overview Table 76. Sarepta Therapeutics Antisense Therapy Products, Services and Solutions Table 77. Revenue (US$ Million) in Antisense Therapy Business of Sarepta Therapeutics (2016-2021) Table 78. Sarepta Therapeutics Recent Developments Table 79. Biogen Basic Information List Table 80. Biogen Description and Business Overview Table 81. Biogen Antisense Therapy Products, Services and Solutions Table 82. Revenue (US$ Million) in Antisense Therapy Business of Biogen (2016-2021) Table 83. Biogen Recent Developments Table 84. North America Antisense Therapy Market Size by Country (2016-2021) & (US$ Million) Table 85. North America Antisense Therapy Market Size by Country (2022-2027) & (US$ Million) Table 86. Europe Antisense Therapy Market Size by Country (2016-2021) & (US$ Million) Table 87. Europe Antisense Therapy Market Size by Country (2022-2027) & (US$ Million) Table 88. Asia-Pacific Antisense Therapy Market Size by Region (2016-2021) & (US$ Million) Table 89. Asia-Pacific Antisense Therapy Market Size by Region (2022-2027) & (US$ Million) Table 90. Asia-Pacific Antisense Therapy Market Share by Region (2016-2021) Table 91. Asia-Pacific Antisense Therapy Market Share by Region (2022-2027) Table 92. Latin America Antisense Therapy Market Size by Country (2016-2021) & (US$ Million) Table 93. Latin America Antisense Therapy Market Size by Country (2022-2027) & (US$ Million) Table 94. Middle East & Africa Antisense Therapy Market Size by Players (2016-2021) & (US$ Million) Table 95. Middle East & Africa Antisense Therapy Market Size by Country (2022-2027) & (US$ Million) Table 96. Antisense Therapy Market Trends Table 97. Antisense Therapy Market Drivers Table 98. Antisense Therapy Market Challenges Table 99. Antisense Therapy Market Restraints Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources List of Figures Figure 1. Global Antisense Therapy Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Antisense Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Antisense Therapy Market Share by Regions: 2021 VS 2027 Figure 4. Global Antisense Therapy Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Antisense Therapy Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Antisense Therapy Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Antisense Therapy Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Antisense Therapy Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Antisense Therapy Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Antisense Therapy Market Size Share by Type in 2021 & 2027 Figure 11. RNA Antisense Therapy Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. DNA Antisense Therapy Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Global Antisense Therapy Market Size Share by Application in 2021 & 2027 Figure 14. Cancer Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Cardiovascular Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. HBV Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Other Market Size (US$ Million) YoY Growth (2016-2027) Figure 18. Antisense Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 19. Global Top 5 and Top 10 Players Antisense Therapy Market Share in 2020 Figure 20. North America Antisense Therapy Market Share by Country (2016-2027) Figure 21. United States Antisense Therapy Market Size (2016-2027) & (US$ Million) Figure 22. Canada Antisense Therapy Market Size (2016-2027) & (US$ Million) Figure 23. Germany Antisense Therapy Market Size (2016-2027) & (US$ Million) Figure 24. France Antisense Therapy Market Size (2016-2027) & (US$ Million) Figure 25. U.K. Antisense Therapy Market Size (2016-2027) & (US$ Million) Figure 26. Italy Antisense Therapy Market Size (2016-2027) & (US$ Million) Figure 27. Russia Antisense Therapy Market Size (2016-2027) & (US$ Million) Figure 28. Nordic Antisense Therapy Market Size (2016-2027) & (US$ Million) Figure 29. Rest of Europe Antisense Therapy Market Size (2016-2027) & (US$ Million) Figure 30. Asia-Pacific Antisense Therapy Market Share by Region (2016-2027) Figure 31. China Antisense Therapy Market Size (2016-2027) & (US$ Million) Figure 32. Japan Antisense Therapy Market Size (2016-2027) & (US$ Million) Figure 33. South Korea Antisense Therapy Market Size (2016-2027) & (US$ Million) Figure 34. Southeast Asia Antisense Therapy Market Size (2016-2027) & (US$ Million) Figure 35. India Antisense Therapy Market Size (2016-2027) & (US$ Million) Figure 36. Australia Antisense Therapy Market Size (2016-2027) & (US$ Million) Figure 37. Rest of Asia-Pacific Antisense Therapy Market Size (2016-2027) & (US$ Million) Figure 38. Latin America Antisense Therapy Market Share by Country (2016-2027) Figure 39. Mexico Antisense Therapy Market Size (2016-2027) & (US$ Million) Figure 40. Brazil Antisense Therapy Market Size (2016-2027) & (US$ Million) Figure 41. Rest of Latin America Antisense Therapy Market Size (2016-2027) & (US$ Million) Figure 42. Middle East & Africa Antisense Therapy Market Share by Country (2016-2027) Figure 43. Turkey Antisense Therapy Market Size (2016-2027) & (US$ Million) Figure 44. Saudi Arabia Antisense Therapy Market Size (2016-2027) & (US$ Million) Figure 45. UAE Antisense Therapy Market Size (2016-2027) & (US$ Million) Figure 46. Rest of Middle East & Africa Antisense Therapy Market Size (2016-2027) & (US$ Million) Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation

Alnylam Pharmaceuticals Ionis Pharmaceuticals, Inc. Arbutus Biopharma (Tekmira) Isarna Therapeutics Arrowhead Dicerna Pharmaceuticals Quark Pharmaceuticals Benitec Biopharma Sylentis Gradalis Sarepta Therapeutics Biogen